A galantamine–curcumin hybrid lacks the depressant side effect of acetylcholinesterase inhibitors
Acetylcholinesterase inhibitors (AChEIs) are drugs that enhance cholinergic neuro-transmission and are used for the treatment of Alzheimer’s disease and myasthenia gravis. Common AChEIs include rivastigmine, donepezil and galantamine (GAL), but they can cause side effects like nausea, vomiting, depr...
Main Authors: | Ivanka Kostadinova, Mariyana Atanasova, Georgi Stavrakov, Irena Philipova, Irini Doytchinova |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2024-12-01
|
Series: | Biotechnology & Biotechnological Equipment |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/13102818.2024.2305903 |
Similar Items
-
A Novel Galantamine–Curcumin Hybrid Inhibits Butyrylcholinesterase: A Molecular Dynamics Study
by: Evdokiya Salamanova, et al.
Published: (2024-12-01) -
A Novel Galantamine-Curcumin Hybrid as a Potential Multi-Target Agent against Neurodegenerative Disorders
by: Rumyana Simeonova, et al.
Published: (2021-03-01) -
Discovery of a Novel Acetylcholinesterase Inhibitor by Fragment-Based Design and Virtual Screening
by: Georgi Stavrakov, et al.
Published: (2021-04-01) -
Galantamine-Curcumin Hybrids as Dual-Site Binding Acetylcholinesterase Inhibitors
by: Georgi Stavrakov, et al.
Published: (2020-07-01) -
Design of Curcumin and Flavonoid Derivatives with Acetylcholinesterase and Beta-Secretase Inhibitory Activities Using in Silico Approaches
by: Thai-Son Tran, et al.
Published: (2020-08-01)